ClinicalTrials.Veeva

Menu
Advanced Research Institute | Reno, NV logo

Advanced Research Institute | Reno, NV

Research site

Site insights

Top conditions

Top treatments

Vonoprazan
Tirzepatide
Lansoprazole
IW-3718
ION224
CC-93538
Vibegron
EYE103
deudomperidone
LY3298176

Parent organization

This site is a part of Advanced Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

7 of 20 total trials

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in...

Begins enrollment in 1 month
Metabolic Dysfunction-Associated Steatotic Liver Disease
Drug: Tirzepatide
Drug: Placebo

This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in...

Enrolling
Coeliac Disease
Celiac Disease
Dietary Supplement: SIGE
Drug: Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopa...

Enrolling
Idiopathic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg

This study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with o...

Enrolling
Eosinophilic Duodenitis (EoD)
Eosinophilic Gastroenteritis
Drug: Dupilumab

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Active, not recruiting
Eosinophilic Esophagitis
Drug: CC-93538

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Enrolling
Irritable Bowel Syndrome with Diarrhea
Drug: CIN-103
Drug: Placebo

Trial sponsors

Phathom Pharmaceuticals logo
Lilly logo
Allergan logo
Celgene logo
C
C
E
Exact Sciences Corporation logo
E
F

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems